"Folgrace improves epidermal nerve fiber density (ENFD) in the lower extremity of patients with diabetic peripheral neuropathy (DPN), promotes the restoration of lost cutaneous sensation, and helps manage hyperhomocysteinemia. It also reduces oxidative stress, promotes nerve health, and alleviates symptoms of anesthesia, paresthesia, or dysesthesia. Folgrace is used in the treatment of pregnancy and lactation, hyperhomocysteinemia, and hypocalcemia-induced osteoporosis."